Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
The Gastrointestinal Barrier Function Lab at Mayo Clinic uses state-of-the-art techniques to characterize sensory, motor and barrier function in study volunteers.
Dr. Grover's laboratory develops novel techniques for measurement of mucosal barrier and secretory function.
Confocal, super-resolution and electron microscopy are routinely utilized in the lab's studies.
The Gastrointestinal Barrier Function Lab is expanding on techniques for assessing barrier function in response to bacteria and other luminal mediators.
Dr. Grover's lab focuses on pathophysiology of Campylobacter postinfectious IBS and develops novel models to study the mechanisms of the disease.
The Gastrointestinal Barrier Function Lab conducts clinical trials and basic science research to better understand IBS and other gastrointestinal disorders and test new therapeutic targets.
Research projects and collaborations in the lab advance understanding and treatment of postinfectious irritable bowel syndrome, gastroparesis, functional dyspepsia and more.
The lab conducts clinical trials to test the effectiveness, safety and performance of drugs to measure small intestinal permeability and to treat people with IBS or functional dyspepsia.
Keep up to date with research outcomes and findings on irritable bowel syndrome, gastroparesis, functional dyspepsia and more with published research articles from Dr. Grover's lab.
Contact the Gastrointestinal Barrier Function Laboratory at Mayo Clinic with inquiries about IBS and gastrointestinal health research, collaborations, clinical trials or career opportunities.